Please login to the form below

Not currently logged in
Email:
Password:

Trumenba

This page shows the latest Trumenba news and features for those working in and with pharma, biotech and healthcare.

Pfizer wins EU approval for MenB vaccine Trumenba

Pfizer wins EU approval for MenB vaccine Trumenba

Pfizer wins EU approval for MenB vaccine Trumenba. US pharma firm’s injection can now be given to patients aged 10 and above. ... Trumenba has been approved in Europe to prevent MenB in people aged 10 or above, more than four years after Bexsero first

Latest news

  • Keytruda and Opdivo backed for new uses in Europe Keytruda and Opdivo backed for new uses in Europe

    Keytruda and Opdivo backed for new uses in Europe. CHMP recommendations also include Trumenba, Dinutuximab beta and Refixia. ... Trumenba has been approved for children aged 10 years or older, while Bexsero can be administered from two months.

  • Pfizer posts positive Trumenba vaccine data Pfizer posts positive Trumenba vaccine data

    Pfizer posts positive Trumenba vaccine data. Results from two new trials support FDA decision for accelerated approval. ... Pfizer's Trumenba vaccine for meningitis B has shown favourable results in two phase III trials.

  • US expands recommended use of meningitis B vaccines US expands recommended use of meningitis B vaccines

    US expands recommended use of meningitis B vaccines. Butopts not to back routine use of GSK's Bexsero and Pfizer' Trumenba. ... But the panel - part of the US Centers for Disease Control and Prevention (CDC) - opted not to recommend routine vaccination

  • Pfizer teams up with snowboarder in meningitis campaign Pfizer teams up with snowboarder in meningitis campaign

    Pfizer's recent developments in meningitis include the FDA approval of its meningitis B vaccine Trumenba in October this year, ahead of a decision on Novartis' rival vaccine Bexsero.

  • Pfizer gets FDA nod for meningitis vaccine Trumenba Pfizer gets FDA nod for meningitis vaccine Trumenba

    Pfizer gets FDA nod for meningitis vaccine Trumenba. Ahead of Novartis’ rival drug Bexsero. ... Pfizer's Trumenba has become the first vaccine licensed in the US to protection meningitis B (menB), ahead of rival Bexsero from Novartis.

More from news
Approximately 5 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics